Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by Don2018on Dec 22, 2019 10:51pm
200 Views
Post# 30482560

RE:Katusa sold at $1.08 ...

RE:Katusa sold at $1.08 ...
mesa1 wrote: Marin Katusa on Aug 22 recommended taking the tax loss on Pipestone at $1.08. He figured the larger caps are so cheap right now, that you don’t need to take any execution risk. 

I wonder how that worked out for him? ;-)


I wonder as well?

"Execution risk" ?????? WTF is that goof smoking? The production increase was already in the bag at that time.

PIPE has done nothing but under-promise and over-deliver. Katusa could take some investing lessons from PIPE's management, IMO

<< Previous
Bullboard Posts
Next >>